179 related articles for article (PubMed ID: 3499930)
1. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases.
Dührsen U; Augener W; Zwingers T; Brittinger G
Br J Haematol; 1987 Oct; 67(2):235-9. PubMed ID: 3499930
[TBL] [Abstract][Full Text] [Related]
2. Rheumatological manifestations of haematological diseases.
Menon S; Isenberg DA
Ann Rheum Dis; 1995 Oct; 54(10):787-95. PubMed ID: 7492215
[No Abstract] [Full Text] [Related]
3. Indications for bone marrow examination in autoimmune disorders with concurrent haematologic alterations.
Papageorgiou A; Ziakas PD; Tzioufas AG; Voulgarelis M
Clin Exp Rheumatol; 2013; 31(1):76-83. PubMed ID: 23010147
[TBL] [Abstract][Full Text] [Related]
4. Systemic disorders with rheumatic manifestations.
Curr Opin Rheumatol; 1989 Dec; 1(4):573-6. PubMed ID: 2702063
[No Abstract] [Full Text] [Related]
5. Clinical characteristics of patients with lymphoproliferative neoplasms in the setting of systemic autoimmune diseases.
Suvajdzic N; Djurdjevic P; Todorovic M; Perunicic M; Stojanović R; Novkovic A; Mihaljevic B
Med Oncol; 2012 Sep; 29(3):2207-11. PubMed ID: 21755372
[TBL] [Abstract][Full Text] [Related]
6. [Concurrent lymphoproliferative and myeloproliferative disorders in three patients].
Hernández Sánchez MC; García Quiroga H; Ulibarrena Redondo C; Méndez Sánchez JA
An Med Interna; 2008 Feb; 25(2):78-80. PubMed ID: 18432364
[TBL] [Abstract][Full Text] [Related]
7. [Hospital infections in patients with hematologic diseases].
Sidorova LD; Bondar' IA
Probl Gematol Pereliv Krovi; 1982 May; 27(5):3-5. PubMed ID: 7100143
[No Abstract] [Full Text] [Related]
8. Coexistence of sarcoidosis and malignant disease: causality or coincidence?
Brincker H
Sarcoidosis; 1989 Mar; 6(1):31-43. PubMed ID: 2657921
[TBL] [Abstract][Full Text] [Related]
9. Association of myeloproliferative and lymphoproliferative disorders.
Gaillard JB; Carillo S; Henry L; Jourdan E; Lavabre-Bertrand T
Clin Adv Hematol Oncol; 2012 Nov; 10(11):756-7. PubMed ID: 23271265
[No Abstract] [Full Text] [Related]
10. Immunodeficiency and lymphoproliferative disorders.
Hermaszewski RA; Ratnavel RC; Denman DJ; Denman AM; Webster AD
Baillieres Clin Rheumatol; 1991 Aug; 5(2):277-300. PubMed ID: 1756585
[No Abstract] [Full Text] [Related]
11. Hypersplenism and splenectomy in lymphoproliferative and myeloproliferative disorders.
Kesteven PJ; Pullan JM; Glass UH; Wetherley-Mein G
Clin Lab Haematol; 1985; 7(4):297-306. PubMed ID: 3830529
[TBL] [Abstract][Full Text] [Related]
12. [Vasculitis and malignant diseases].
Gran JT
Tidsskr Nor Laegeforen; 1997 Apr; 117(11):1627-9. PubMed ID: 9198948
[TBL] [Abstract][Full Text] [Related]
13. Early postoperative course following elective splenectomy in haematological diseases: a high complication rate in patients with myeloproliferative disorders.
Malmaeus J; Akre T; Adami HO; Hagberg H
Br J Surg; 1986 Sep; 73(9):720-3. PubMed ID: 3756435
[TBL] [Abstract][Full Text] [Related]
14. [Auto-immune diseases and cancers. Second part: auto-immune diseases complicating cancers and their treatment].
Pasquet F; Pavic M; Ninet J; Hot A
Rev Med Interne; 2014 Oct; 35(10):656-63. PubMed ID: 25106665
[TBL] [Abstract][Full Text] [Related]
15. Acquired von Willebrand factor abnormalities in myeloproliferative disorders and other hematologic diseases: a retrospective analysis by a single institution.
Sánchez-Luceros A; Meschengieser SS; Woods AI; Blanco AN; Kempfer AC; Casais P; Salviú MJ; Lazzari MA
Haematologica; 2002 Mar; 87(3):264-70. PubMed ID: 11869938
[TBL] [Abstract][Full Text] [Related]
16. Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort.
Holst JM; Plesner TL; Pedersen MB; Frederiksen H; Møller MB; Clausen MR; Hansen MC; Hamilton-Dutoit SJ; Nørgaard P; Johansen P; Ramm Eberlein T; Mortensen BK; Mathiasen G; Øvlisen A; Wang R; Wang C; Zhang W; Beier Ommen H; Stentoft J; Ludvigsen M; Tam W; Chan WC; Inghirami G; d'Amore F
Haematologica; 2020 Oct; 105(10):2432-2439. PubMed ID: 33054083
[TBL] [Abstract][Full Text] [Related]
17. [Hematological abnormalities in rheumatic diseases].
Radman I
Reumatizam; 2006; 53(2):11-7. PubMed ID: 17580549
[TBL] [Abstract][Full Text] [Related]
18. Acquired von Willebrand syndrome: an important bleeding complication to be considered in patients with lymphoproliferative and myeloproliferative disorders.
Federici AB; Rand JH; Mannucci PM
Hematol J; 2001; 2(6):358-62. PubMed ID: 11920274
[No Abstract] [Full Text] [Related]
19. Myeloproliferative and lymphoproliferative disorders in the same patient.
Iland H; Chan W; Vincent PC
Aust N Z J Med; 1980 Dec; 10(6):650-3. PubMed ID: 6938186
[TBL] [Abstract][Full Text] [Related]
20. Biological therapy and development of neoplastic disease in patients with juvenile rheumatic disease: a systematic review.
Pereira VPL; Robazzi TCMV
Rev Bras Reumatol Engl Ed; 2017; 57(2):174-181. PubMed ID: 28343623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
